The LIM-homeodomain transcription factor LMX1B regulates expression of NF-kappa B target genes

Experimental Cell Research

Volumn 315, Issue 1, 2009, Pages 76-96

  Rascle, Anne ^a   Neumann, Tanja ^a   Raschta, Anne Sarah ^a   Neumann, Astrid ^a   Heining, Eva ^a   Kastner, Juergen ^a   Witzgall, Ralph ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

ChIP assay; Chromatin; Gene expression profiling; Knock out mouse; LMX1B; Luciferase reporter assay; NF B; siRNA mediated knock down; Tet off expression system; Transcription

Indexed keywords

DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; NUCLEAR PROTEIN; PROTEIN P50; RNA; SYNAPTOTAGMIN I; TETRACYCLINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR LMX1B; UNCLASSIFIED DRUG;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENE TARGETING; HELA CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; MICROANALYSIS; PRIORITY JOURNAL; PROTEIN BINDING; TRANSCRIPTION REGULATION; UPREGULATION;

MUS;

EID: 56949101429     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2008.10.012     Document Type: Article

References (85)

1. Bach I. The LIM domain: regulation by association. Mech. Dev. 91 (2000) 5-17
2. Hunter C.S., and Rhodes S.J. LIM-homeodomain genes in mammalian development and human disease. Mol. Biol. Rep. 32 (2005) 67-77
3. Gehring W.J., Affolter M., and Burglin T. Homeodomain proteins. Annu. Rev. Biochem. 63 (1994) 487-526
4. Gehring W.J., Qian Y.Q., Billeter M., Furukubo-Tokunaga K., Schier A.F., Resendez-Perez D., Affolter M., Otting G., and Wuthrich K. Homeodomain-DNA recognition. Cell 78 (1994) 211-223
5. Matthews J.M., and Visvader J.E. LIM-domain-binding protein 1: a multifunctional cofactor that interacts with diverse proteins. EMBO Rep. 4 (2003) 1132-1137
6. Agulnick A.D., Taira M., Breen J.J., Tanaka T., Dawid I.B., and Westphal H. Interactions of the LIM-domain-binding factor Ldb1 with LIM homeodomain proteins. Nature 384 (1996) 270-272
7. Jurata L.W., and Gill G.N. Functional analysis of the nuclear LIM domain interactor NLI. Mol. Cell Biol. 17 (1997) 5688-5698
8. Jurata L.W., Kenny D.A., and Gill G.N. Nuclear LIM interactor, a rhombotin and LIM homeodomain interacting protein, is expressed early in neuronal development. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 11693-11698
9. Jurata L.W., Pfaff S.L., and Gill G.N. The nuclear LIM domain interactor NLI mediates homo- and heterodimerization of LIM domain transcription factors. J. Biol. Chem. 273 (1998) 3152-3157
10. Bach I., Rodriguez-Esteban C., Carriere C., Bhushan A., Krones A., Rose D.W., Glass C.K., Andersen B., Izpisua Belmonte J.C., and Rosenfeld M.G. RLIM inhibits functional activity of LIM homeodomain transcription factors via recruitment of the histone deacetylase complex. Nat. Genet. 22 (1999) 394-399
11. Ostendorff H.P., Peirano R.I., Peters M.A., Schluter A., Bossenz M., Scheffner M., and Bach I. Ubiquitination-dependent cofactor exchange on LIM homeodomain transcription factors. Nature 416 (2002) 99-103
12. Asbreuk C.H., Vogelaar C.F., Hellemons A., Smidt M.P., and Burbach J.P. CNS expression pattern of Lmx1b and coexpression with ptx genes suggest functional cooperativity in the development of forebrain motor control systems. Mol. Cell Neurosci. 21 (2002) 410-420
13. Chen H., Lun Y., Ovchinnikov D., Kokubo H., Oberg K.C., Pepicelli C.V., Gan L., Lee B., and Johnson R.L. Limb and kidney defects in Lmx1b mutant mice suggest an involvement of LMX1B in human nail patella syndrome. Nat. Genet. 19 (1998) 51-55
14. Chen H., Ovchinnikov D., Pressman C.L., Aulehla A., Lun Y., and Johnson R.L. Multiple calvarial defects in lmx1b mutant mice. Dev. Genet. 22 (1998) 314-320
15. Cygan J.A., Johnson R.L., and McMahon A.P. Novel regulatory interactions revealed by studies of murine limb pattern in Wnt-7a and En-1 mutants. Development 124 (1997) 5021-5032
16. Dai J.X., Hu Z.L., Shi M., Guo C., and Ding Y.Q. Postnatal ontogeny of the transcription factor Lmx1b in the mouse central nervous system. J. Comp. Neurol. 509 (2008) 341-355
17. Ding Y.Q., Marklund U., Yuan W., Yin J., Wegman L., Ericson J., Deneris E., Johnson R.L., and Chen Z.F. Lmx1b is essential for the development of serotonergic neurons. Nat. Neurosci. 6 (2003) 933-938
18. Guo C., Qiu H.Y., Huang Y., Chen H., Yang R.Q., Chen S.D., Johnson R.L., Chen Z.F., and Ding Y.Q. Lmx1b is essential for Fgf8 and Wnt1 expression in the isthmic organizer during tectum and cerebellum development in mice. Development 134 (2007) 317-325
19. Pressman C.L., Chen H., and Johnson R.L. LMX1B, a LIM homeodomain class transcription factor, is necessary for normal development of multiple tissues in the anterior segment of the murine eye. Genesis 26 (2000) 15-25
20. Riddle R.D., Ensini M., Nelson C., Tsuchida T., Jessell T.M., and Tabin C. Induction of the LIM homeobox gene Lmx1 by WNT7a establishes dorsoventral pattern in the vertebrate limb. Cell 83 (1995) 631-640
21. Smidt M.P., Asbreuk C.H., Cox J.J., Chen H., Johnson R.L., and Burbach J.P. A second independent pathway for development of mesencephalic dopaminergic neurons requires Lmx1b. Nat. Neurosci. 3 (2000) 337-341
22. McIntosh I., Dunston J.A., Liu L., Hoover-Fong J.E., and Sweeney E. Nail patella syndrome revisited: 50 years after linkage. Ann. Hum. Genet. 69 (2005) 349-363
23. Rascle A., Suleiman H., Neumann T., and Witzgall R. Role of transcription factors in podocytes. Nephron, Exp. Nephrol. 106 (2007) e60-e66
24. Miner J.H., Morello R., Andrews K.L., Li C., Antignac C., Shaw A.S., and Lee B. Transcriptional induction of slit diaphragm genes by Lmx1b is required in podocyte differentiation. J. Clin. Invest. 109 (2002) 1065-1072
25. Rohr C., Prestel J., Heidet L., Hosser H., Kriz W., Johnson R.L., Antignac C., and Witzgall R. The LIM-homeodomain transcription factor Lmx1b plays a crucial role in podocytes. J. Clin. Invest. 109 (2002) 1073-1082
26. Suleiman H., Heudobler D., Raschta A.S., Zhao Y., Zhao Q., Hertting I., Vitzthum H., Moeller M.J., Holzman L.B., Rachel R., Johnson R., Westphal H., Rascle A., and Witzgall R. The podocyte-specific inactivation of Lmx1b, Ldb1 and E2a yields new insight into a transcriptional network in podocytes. Dev. Biol. 304 (2007) 701-712
27. Dunston J.A., Reimschisel T., Ding Y.Q., Sweeney E., Johnson R.L., Chen Z.F., and McIntosh I. A neurological phenotype in nail patella syndrome (NPS) patients illuminated by studies of murine Lmx1b expression. Eur. J. Hum. Genet. 13 (2005) 330-335
28. Bongers E.M., Gubler M.C., and Knoers N.V. Nail-patella syndrome. Overview on clinical and molecular findings. Pediatr. Nephrol. 17 (2002) 703-712
29. German M.S., Wang J., Chadwick R.B., and Rutter W.J. Synergistic activation of the insulin gene by a LIM-homeo domain protein and a basic helix-loop-helix protein: building a functional insulin minienhancer complex. Genes Dev. 6 (1992) 2165-2176
30. Johnson J.D., Zhang W., Rudnick A., Rutter W.J., and German M.S. Transcriptional synergy between LIM-homeodomain proteins and basic helix-loop-helix proteins: the LIM2 domain determines specificity. Mol. Cell Biol. 17 (1997) 3488-3496
31. Marini M., Bongers E.M., Cusano R., Di Duca M., Seri M., Knoers N.V., and Ravazzolo R. Confirmation of CLIM2/LMX1B interaction by yeast two-hybrid screening and analysis of its involvement in nail-patella syndrome. Int. J. Mol. Med. 12 (2003) 79-82
32. Dreyer S.D., Morello R., German M.S., Zabel B., Winterpacht A., Lunstrum G.P., Horton W.A., Oberg K.C., and Lee B. LMX1B transactivation and expression in nail-patella syndrome. Hum. Mol. Genet. 9 (2000) 1067-1074
33. Dreyer S.D., Naruse T., Morello R., Zabel B., Winterpacht A., Johnson R.L., Lee B., and Oberg K.C. Lmx1b expression during joint and tendon formation: localization and evaluation of potential downstream targets. Gene Expr. Patterns 4 (2004) 397-405
34. Krawchuk D., and Kania A. Identification of genes controlled by LMX1B in the developing mouse limb bud. Dev. Dyn. 237 (2008) 1183-1192
35. Morello R., Zhou G., Dreyer S.D., Harvey S.J., Ninomiya Y., Thorner P.S., Miner J.H., Cole W., Winterpacht A., Zabel B., Oberg K.C., and Lee B. Regulation of glomerular basement membrane collagen expression by LMX1B contributes to renal disease in nail patella syndrome. Nat. Genet. 27 (2001) 205-208
36. Heidet L., Bongers E.M., Sich M., Zhang S.Y., Loirat C., Meyrier A., Broyer M., Landthaler G., Faller B., Sado Y., Knoers N.V., and Gubler M.C. In vivo expression of putative LMX1B targets in nail-patella syndrome kidneys. Am. J. Pathol. 163 (2003) 145-155
37. Gossen M., and Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 5547-5551
38. Van den Berghe W., Plaisance S., Boone E., De Bosscher K., Schmitz M.L., Fiers W., and Haegeman G. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor. J. Biol. Chem. 273 (1998) 3285-3290
39. Dong Y., Skoultchi A.I., and Pollard J.W. Efficient DNA transfection of quiescent mammalian cells using poly-l-ornithine. Nucleic Acids Res. 21 (1993) 771-772
40. Cockett M.I., Ochalski R., Benwell K., Franco R., and Wardwell-Swanson J. Simultaneous expression of multi-subunit proteins in mammalian cells using a convenient set of mammalian cell expression vectors. BioTechniques 23 (1997) 402-407
41. Koulen P., Cai Y., Geng L., Maeda Y., Nishimura S., Witzgall R., Ehrlich B.E., and Somlo S. Polycystin-2 is an intracellular calcium release channel. Nat. Cell Biol. 4 (2002) 191-197
42. Basham B., Sathe M., Grein J., McClanahan T., D'Andrea A., Lees E., and Rascle A. In vivo identification of novel STAT5 target genes. Nucleic Acids Res. 36 (2008) 3802-3818
43. Rascle A., Johnston J.A., and Amati B. Deacetylase activity is required for recruitment of the basal transcription machinery and transactivation by STAT5. Mol. Cell Biol. 23 (2003) 4162-4173
44. Rascle A., and Lees E. Chromatin acetylation and remodeling at the cis promoter during STAT5-induced transcription. Nucleic Acids Res. 31 (2003) 6882-6890
45. Sledz C.A., Holko M., de Veer M.J., Silverman R.H., and Williams B.R. Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol. 5 (2003) 834-839
46. Lee U.J., Choung S.R., Prakash K.V., Lee E.J., Lee M.Y., Kim Y.J., Han C.W., and Choi Y.C. Dual knockdown of p65 and p50 subunits of NF-kappaB by siRNA inhibits the induction of inflammatory cytokines and significantly enhance apoptosis in human primary synoviocytes treated with tumor necrosis factor-alpha. Mol. Biol. Rep. (2007)
47. Cozzi A., Corsi B., Levi S., Santambrogio P., Albertini A., and Arosio P. Overexpression of wild type and mutated human ferritin H-chain in HeLa cells: in vivo role of ferritin ferroxidase activity. J. Biol. Chem. 275 (2000) 25122-25129
48. Vollrath D., Jaramillo-Babb V.L., Clough M.V., McIntosh I., Scott K.M., Lichter P.R., and Richards J.E. Loss-of-function mutations in the LIM-homeodomain gene, LMX1B, in nail-patella syndrome. Hum. Mol. Genet. 7 (1998) 1091-1098
49. Michelsen J.W., Sewell A.K., Louis H.A., Olsen J.I., Davis D.R., Winge D.R., and Beckerle M.C. Mutational analysis of the metal sites in an LIM domain. J. Biol. Chem. 269 (1994) 11108-11113
50. Agalioti T., Lomvardas S., Parekh B., Yie J., Maniatis T., and Thanos D. Ordered recruitment of chromatin modifying and general transcription factors to the IFN-beta promoter. Cell 103 (2000) 667-678
51. Lenardo M.J., Fan C.M., Maniatis T., and Baltimore D. The involvement of NF-kappa B in beta-interferon gene regulation reveals its role as widely inducible mediator of signal transduction. Cell 57 (1989) 287-294
52. Doly J., Civas A., Navarro S., and Uze G. Type I interferons: expression and signalization. Cell Mol. Life Sci. 54 (1998) 1109-1121
53. Hoffmann A., Natoli G., and Ghosh G. Transcriptional regulation via the NF-kappaB signaling module. Oncogene 25 (2006) 6706-6716
54. Bonizzi G., and Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25 (2004) 280-288
55. Tian B., Nowak D.E., and Brasier A.R. A TNF-induced gene expression program under oscillatory NF-kappaB control. BMC Genomics 6 (2005) 137
56. Tian B., Nowak D.E., Jamaluddin M., Wang S., and Brasier A.R. Identification of direct genomic targets downstream of the nuclear factor-kappaB transcription factor mediating tumor necrosis factor signaling. J. Biol. Chem. 280 (2005) 17435-17448
57. Li H., and Lin X. Positive and negative signaling components involved in TNFalpha-induced NF-kappaB activation. Cytokine 41 (2008) 1-8
58. Bosisio D., Marazzi I., Agresti A., Shimizu N., Bianchi M.E., and Natoli G. A hyper-dynamic equilibrium between promoter-bound and nucleoplasmic dimers controls NF-kappaB-dependent gene activity. EMBO J. 25 (2006) 798-810
59. Takada N., Sanda T., Okamoto H., Yang J.P., Asamitsu K., Sarol L., Kimura G., Uranishi H., Tetsuka T., and Okamoto T. RelA-associated inhibitor blocks transcription of human immunodeficiency virus type 1 by inhibiting NF-kappaB and Sp1 actions. J. Virol. 76 (2002) 8019-8030
60. Yang J.P., Hori M., Sanda T., and Okamoto T. Identification of a novel inhibitor of nuclear factor-kappaB, RelA-associated inhibitor. J. Biol. Chem. 274 (1999) 15662-15670
61. Chariot A., Princen F., Gielen J., Merville M.P., Franzoso G., Brown K., Siebenlist U., and Bours V. IkappaB-alpha enhances transactivation by the HOXB7 homeodomain-containing protein. J. Biol. Chem. 274 (1999) 5318-5325
62. Merika M., and Thanos D. Enhanceosomes. Curr. Opin. Genet. Dev. 11 (2001) 205-208
63. Bange F.C., Vogel U., Flohr T., Kiekenbeck M., Denecke B., and Bottger E.C. IFP 35 is an interferon-induced leucine zipper protein that undergoes interferon-regulated cellular redistribution. J. Biol. Chem. 269 (1994) 1091-1098
64. Bluyssen H.A., Vlietstra R.J., Faber P.W., Smit E.M., Hagemeijer A., and Trapman J. Structure, chromosome localization, and regulation of expression of the interferon-regulated mouse Ifi54/Ifi56 gene family. Genomics 24 (1994) 137-148
65. de Veer M.J., Holko M., Frevel M., Walker E., Der S., Paranjape J.M., Silverman R.H., and Williams B.R. Functional classification of interferon-stimulated genes identified using microarrays. J. Leukoc. Biol. 69 (2001) 912-920
66. Drouet C., and Reboul A. Biosynthesis of C1r and C1s subcomponents. Behring-Inst.-Mitt. (1989) 80-88
67. Grotzinger T., Sternsdorf T., Jensen K., and Will H. Interferon-modulated expression of genes encoding the nuclear-dot-associated proteins Sp100 and promyelocytic leukemia protein (PML). Eur. J. Biochem. 238 (1996) 554-560
68. Helbig G., Christopherson III K.W., Bhat-Nakshatri P., Kumar S., Kishimoto H., Miller K.D., Broxmeyer H.E., and Nakshatri H. NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J. Biol. Chem. 278 (2003) 21631-21638
69. Hiscott J., Marois J., Garoufalis J., D'Addario M., Roulston A., Kwan I., Pepin N., Lacoste J., Nguyen H., Bensi G., et al. Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop. Mol. Cell Biol. 13 (1993) 6231-6240
70. Kang D.C., Gopalkrishnan R.V., Wu Q., Jankowsky E., Pyle A.M., and Fisher P.B. mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 637-642
71. Kiss J., Yegutkin G.G., Koskinen K., Savunen T., Jalkanen S., and Salmi M. IFN-beta protects from vascular leakage via up-regulation of CD73. Eur. J. Immunol. 37 (2007) 3334-3338
72. Kulaeva O.I., Draghici S., Tang L., Kraniak J.M., Land S.J., and Tainsky M.A. Epigenetic silencing of multiple interferon pathway genes after cellular immortalization. Oncogene 22 (2003) 4118-4127
73. Kunsch C., and Rosen C.A. NF-kappa B subunit-specific regulation of the interleukin-8 promoter. Mol. Cell Biol. 13 (1993) 6137-6146
74. Libermann T.A., and Baltimore D. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol. Cell Biol. 10 (1990) 2327-2334
75. Miettinen M., Sareneva T., Julkunen I., and Matikainen S. IFNs activate toll-like receptor gene expression in viral infections. Genes Immun. 2 (2001) 349-355
76. Moriuchi H., Moriuchi M., and Fauci A.S. Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. J. Immunol. 158 (1997) 3483-3491
77. Niikura T., Hirata R., and Weil S.C. A novel interferon-inducible gene expressed during myeloid differentiation. Blood Cells Mol. Dis. 23 (1997) 337-349
78. Ohmori Y., and Hamilton T.A. Cooperative interaction between interferon (IFN) stimulus response element and kappa B sequence motifs controls IFN gamma- and lipopolysaccharide-stimulated transcription from the murine IP-10 promoter. J. Biol. Chem. 268 (1993) 6677-6688
79. Schreiber J., Jenner R.G., Murray H.L., Gerber G.K., Gifford D.K., and Young R.A. Coordinated binding of NF-kappaB family members in the response of human cells to lipopolysaccharide. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 5899-5904
80. Schreiner B., Mitsdoerffer M., Kieseier B.C., Chen L., Hartung H.P., Weller M., and Wiendl H. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis. J. Neuroimmunol. 155 (2004) 172-182
81. Sun S.C., Ganchi P.A., Ballard D.W., and Greene W.C. NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. Science 259 (1993) 1912-1915
82. Tensen C.P., Flier J., Rampersad S.S., Sampat-Sardjoepersad S., Scheper R.J., Boorsma D.M., and Willemze R. Genomic organization, sequence and transcriptional regulation of the human CXCL 11(1) gene. Biochim. Biophys. Acta 1446 (1999) 167-172
83. Ueda A., Okuda K., Ohno S., Shirai A., Igarashi T., Matsunaga K., Fukushima J., Kawamoto S., Ishigatsubo Y., and Okubo T. NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J. Immunol. 153 (1994) 2052-2063
84. Widmer U., Manogue K.R., Cerami A., and Sherry B. Genomic cloning and promoter analysis of macrophage inflammatory protein (MIP)-2, MIP-1 alpha, and MIP-1 beta, members of the chemokine superfamily of proinflammatory cytokines. J. Immunol. 150 (1993) 4996-5012
85. Wong L.H., Sim H., Chatterjee-Kishore M., Hatzinisiriou I., Devenish R.J., Stark G., and Ralph S.J. Isolation and characterization of a human STAT1 gene regulatory element. Inducibility by interferon (IFN) types I and II and role of IFN regulatory factor-1. J. Biol. Chem. 277 (2002) 19408-19417